DXSP DXS International PLC

DXS International plc (AQSE:DXSP): ExpertCare featured in Innovate UK Research Project

DXS International plc (AQSE:DXSP): ExpertCare featured in Innovate UK Research Project

DXS INTERNATIONAL PLC (AQSE: DXSP)

ExpertCare featured in Innovate UK Research Project

DXS International plc ("DXS" or "the Company"), a leading provider of digital clinical decision support solutions, is thrilled to announce that its leading-edge digital health solution, ExpertCare, has been independently reviewed by the prestigious York Health Economics Consortium (YHEC) with results that confirm its powerful impact on both clinical outcomes and NHS cost-efficiency. 

Funded by DXS and Innovate UK and delivered in partnership with Health Innovation East, the evaluation assessed ExpertCare’s effectiveness in supporting medicines optimisation for patients with hypertension. The study, involving 2,484 patients across 13 UK GP practices, compared ExpertCare against standard hypertension review for GP practices. 

The evaluation found that ExpertCare delivers more effective hypertension control, reduces treatment variability, and is cost-saving in both the short and long term. 

The YHEC report concluded that: 

  • ExpertCare significantly increases the number of patients with optimally managed hypertension. 
  • For every £1 invested, ExpertCare returns £2.70 to the NHS. 

ExpertCare functions as an intelligent clinical decision support tool, streamlining data collection and generating treatment recommendations aligned with NICE guidelines—freeing up clinical time and improving outcomes at scale. 

David Immelman, CEO of DXS, commented: 

“We are incredibly proud of the results of this independent validation. It affirms our belief that ExpertCare has the potential to materially improve hypertension management across England, while reducing the cost burden on the NHS. These results highlight the real-world value of deploying ExpertCare nationally starting from year one.” 

For more information, please visit  

Contacts:

David Immelman



DXS International plc



-systems.com



 
01252 719800
AQSE Corporate Broker and Corporate Advisor



Hybridan LLP



Claire Louise Noyce
020 3764 2341

Notes to Editors

About DXS:

DXS International presents up to date treatment guidelines and recommendations, from Clinical Commissioning Groups and other trusted NHS sources, to doctors, nurses and pharmacists in their workflow and during the patient consultation. This effective clinical decision support ultimately translates to improved healthcare outcomes delivered more cost effectively and which should significantly contribute towards the NHS achieving its projected efficiency savings.

Attachment



EN
10/07/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on DXS International PLC

Hybridan Team ... (+2)
  • Hybridan Team
  • Jon Levinson

Hybridan Small Cap Feast: 18 December 2025

Wishing you all Merry Christmas! Back 12 January 2026. * A corporate client of Hybridan LLP. ** Potential means Intention to Float (ITF) or similar announcement has been made. ***Arranged by type of listing and date of announcement. ****Alphabetically arranged and priced on Share Price and Market Capitalisation during the time of writing on the day of Publication. Dish of the Day Admissions: Cornish Metals (TIN.L) the mineral exploration and development Company focused on a...

 PRESS RELEASE

DXS International plc (AQSE: DXSP): Statement for the 2025 Annual Gene...

DXS International plc (AQSE: DXSP): Statement for the 2025 Annual General Meeting 18 December 2025 DXS INTERNATIONAL PLC (AQSE: DXSP) Statement for the 2025 Annual General Meeting The Board of DXS International plc (“the Company” or “DXSP”), the AQSE Growth Market quoted healthcare information and digital clinical decision support systems provider, will hold its Annual General Meeting at 11.30 today, at Elm House, Tanshire Park, Shackleford Road. Elstead, Surrey GU8 6LB, as announced at 7am on 24 November in an RNS announcement. Copies of the AGM documents, along with the Company's Annu...

 PRESS RELEASE

DXS International plc (AQSE:DXSP) Notice of Cyber Security Incident

DXS International plc (AQSE:DXSP) Notice of Cyber Security Incident 18 December 2025 DXS INTERNATIONAL PLC (AQSE: DXSP) Notice of Cyber Security Incident The Board of DXS International plc (“the Company” or “DXSP”), the AQSE Growth Market quoted healthcare information and digital clinical decision support systems provider, reports that it has suffered a security incident affecting its office servers, which was discovered in the early hours of Sunday morning, the 14th December. Once discovered, the data security breach was immediately contained by means of a joint effort by DXS’s interna...

 PRESS RELEASE

DXS INTERNATIONAL PLC (AQSE: DXSP): Notice of 2025 Annual General Meet...

DXS INTERNATIONAL PLC (AQSE: DXSP): Notice of 2025 Annual General Meeting Monday 24 November DXS INTERNATIONAL PLC (AQSE: DXSP) Notice of 2025 Annual General Meeting The Board of DXS International plc (“the Company” or “DXSP”), the AQSE Growth Market quoted healthcare information and digital clinical decision support systems provider, is pleased to announce that its Annual General Meeting is scheduled to take place on Thursday 18th December at 11.30 at Elm House, Tanshire Park, Shackleford Road. Elstead, Surrey GU8 6LB. For further information in relation to the AGM, shareholders should...

 PRESS RELEASE

DXS INTERNATIONAL PLC (AQSE: DXSP) Notification of Director / PDMR Dea...

DXS INTERNATIONAL PLC (AQSE: DXSP) Notification of Director / PDMR Dealing DXS INTERNATIONAL PLC (AQSE: DXSP) Notification of Director / PDMR Dealing DXS INTERNATIONAL PLC The Board of DXS International plc (the “Company” or “DXSP), the AQSE Growth Market quoted clinical decision support developer and supplier of clinical decision support systems, has received notification that on 11 November, Mr Bob Sutcliffe, the Chairman, purchased 50,000 Ordinary Shares in the Company at a price of 1.30p per share. Following this transaction Mr Sutcliffe and his wife’s interest in DXS Ordinary Shares...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch